DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)



company name or ticker

3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)

Benzinga's Top Initiations

Why I'm Still Avoiding Dendreon

Is Dendreon's multi-year epic decline reaching an end, or is there more to come?

Biotech 101: Breakthrough Therapy

BreakthroughtTherapy designation is a term that investors in drugmakers, such as Novartis, Medivation, and Sarepta Therapeutics need to understand.

Medivation Larger Than S&P 500 Component Zions Bancorporation

Biotech Stock Roundup: Medivation Gains on Xtandi Strength, Amgen Scores in Late-Stage Study - Anal

Biotech Stock Roundup: Medivation Gains on Xtandi Strength, Amgen Scores in Late-Stage Study - Analyst Blog

Medivation Inc Stock Upgraded (MDVN)

Strength Seen in Medivation (MDVN): Stock Up 8.5% - Tale of the Tape

Is Dendreon Back on Solid Ground?

Dendreon (DNDN) faces stiff competition from Johnson & Johnson (JNJ) and Medivation (MDVN), but a significant restructuring is lopping off costs in a bid to make the company profitable.

What You Need to Know About Medivation Inc.'s Results

Medivation (MDVN) and Astellas (ALPMY) saw U.S. sales growth slow this quarter, but growth overseas took off. Here's what could be in store for these stocks through the rest of the year.
See More Articles...